The meta-analysis examining differences in MCP-1/CCL-2 levels between participants with severe and non-severe malaria showed a statistically significant increase in MCP-1/CCL-2 levels in patients with severe malaria, with high heterogeneity (I2 = 98%), indicating substantial variability among the included studies. This evidence concerns the gene CCL2 and malaria.